UBS Group
LUMO

UBS Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

UBS Group’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-33
Closed -$11K – 8299
2015
Q4 		$11K Hold
33
– – ﹤0.01% 7244
2015
Q3 		$11K Hold
33
– – ﹤0.01% 7215
2015
Q2 		$13K Sell
33
-56
-63% -$23.8K ﹤0.01% 7271
2015
Q1 		$44K Sell
89
-1,167
-93% -$452K ﹤0.01% 6178
2014
Q4 		$449K Buy
+1,256
New +$374K ﹤0.01% 4301

UBS Group's LUMO Position: Q4 2024 in Review

UBS Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 6,557 shares — an estimated $25.4K sold.

UBS Group first reported a position in LUMO in Q4 2014 and held it in 36 quarters. The position peaked at $2.76M in Q4 2015. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

  • UBS Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • UBS Group sold 6,557 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $25.4K.
  • UBS Group first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2014 and held it in 36 quarters.
  • UBS Group's Lumos Pharma, Inc. Common Stock position peaked at $2.76M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.